VHL and neoplasm: In contrast to similar behaviour of 96 and 97in vitro, solely the phenoxy-linked degrader 97 showcased considerable tumour growth inhibition in mouse xenograft models, possibly due to lower in vivo clearance of 97,181 highlighting the relevance of exploiting different exit vectors at the VHL ligand when designing PROTACs.